disease_transitions:
  NAIVE:
    NAIVE: 0.0
    STABLE: 0.45
    ACTIVE: 0.45
    HIGHLY_ACTIVE: 0.1
  STABLE:
    NAIVE: 0.0
    STABLE: 0.88
    ACTIVE: 0.12
    HIGHLY_ACTIVE: 0.0
  ACTIVE:
    NAIVE: 0.0
    STABLE: 0.35
    ACTIVE: 0.55
    HIGHLY_ACTIVE: 0.1
  HIGHLY_ACTIVE:
    NAIVE: 0.0
    STABLE: 0.1
    ACTIVE: 0.3
    HIGHLY_ACTIVE: 0.6
treatment_effect_on_transitions:
  NAIVE:
    multipliers: {}
  STABLE:
    multipliers:
      STABLE: 1.2
      ACTIVE: 0.8
  ACTIVE:
    multipliers:
      STABLE: 2.5
      ACTIVE: 0.7
      HIGHLY_ACTIVE: 0.5
  HIGHLY_ACTIVE:
    multipliers:
      STABLE: 2.0
      ACTIVE: 1.8
      HIGHLY_ACTIVE: 0.6
vision_change_model:
  naive_treated:
    mean: 3.0
    std: 2.0
  naive_untreated:
    mean: -3.0
    std: 2.0
  stable_treated:
    mean: 1.5
    std: 1.5
  stable_untreated:
    mean: -0.5
    std: 1.0
  active_treated:
    mean: 0.5
    std: 2.0
  active_untreated:
    mean: -3.0
    std: 2.0
  highly_active_treated:
    mean: -0.5
    std: 2.0
  highly_active_untreated:
    mean: -5.0
    std: 3.0
baseline_vision_distribution:
  type: normal
  mean: 55
  std: 15
  min: 20
  max: 85
discontinuation_rules:
  poor_vision_threshold: 35
  poor_vision_probability: 0.05
  high_injection_count: 25
  high_injection_probability: 0.02
  long_treatment_months: 60
  long_treatment_probability: 0.02
  discontinuation_types:
  - planned
  - adverse
  - ineffective
clinical_improvements:
  enabled: true
  use_loading_phase: true
  use_time_based_discontinuation: true
  use_response_based_vision: true
  use_baseline_distribution: false
  use_response_heterogeneity: true
  response_types:
    good:
      probability: 0.6
      multiplier: 1.8
    average:
      probability: 0.5
      multiplier: 1.0
    poor:
      probability: 0.2
      multiplier: 0.5
  discontinuation_probabilities:
    1: 0.1
    2: 0.15
    3: 0.12
    4: 0.08
    5: 0.075
  vision_response_params:
    loading:
      mean: 4.0
      std: 1.5
    year1:
      mean: 1.0
      std: 1.0
    year2:
      mean: 0.0
      std: 1.0
    year3plus:
      mean: -0.3
      std: 1.0
name: Aflibercept T&E Demo
version: '1.0'
created_date: '2025-01-24'
author: Demo
description: T&E protocol using base config
protocol_type: treat_and_extend
min_interval_days: 56
max_interval_days: 112
extension_days: 14
shortening_days: 14
